P

Precigen
D

PGEN

1.13500
USD
-0.04
(-2.99%)
Market Closed
Volume
33,211
EPS
-0
Div Yield
-
P/E
-2
Market Cap
332,406,425
Related Instruments
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BEAM
    1.860
    (7.59%)
    26.380 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    E
    EDIT
    0.15000
    (12.50%)
    1.35000 USD
    N
    NTLA
    1.040
    (10.45%)
    10.990 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    R
    RGNX
    0.28500
    (3.77%)
    7.85000 USD
    S
    SGMO
    0.03500
    (3.13%)
    1.15500 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    More
News

Title: Precigen

Sector: Healthcare
Industry: Biotechnology
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improvedproducts and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.